View
227
Download
0
Category
Preview:
Citation preview
8/12/2019 Surya Corp
1/13
11
8/12/2019 Surya Corp
2/13
The Company isone of the largest exporters
of Mint/Menthol derivativesRevenue of over USD 250 mm
SPL ranks398 in the prestigious
FORTUNE India 500 list &
Ranked no: 20 in
Indian Pharmaceutical Sector
Strong Internal Competencies
World class Manufacturing & R&D
Strong Supply Chain & fastest growing
company
Trusted IndianBrand
SPLAn Introduction
ProfessionallyManageSPLhas been awarded EXCELLENTSUPPLIER (Best Competitiveness)
AWARD OFTHE one of the biggest
Pharmaceutical manufacturers
in Hong KongYEAR by Bright Future
Pharmaceutical laboratories Ltd,!!
8/12/2019 Surya Corp
3/13
Surya Corp
Established in the year 1992, Surya Pharmaceutical Ltd today is one of the leading integrated and multi-
dimensional pharmaceutical group of India which is growing and expanding very fast
A stronghold in API- especially B-LACTUMS and CEPHALOSPORINES with 8 state of the art manufacturing
units
Largest producer & exporter of Menthol & menthol based products to more than 90 countries
Branded formulations with 6 SBUS Covering various Therapeutic segments including nutritional products
is operational at PAN India level.
Surya Corp. is having its own chain of retail pharmacy stores with the Brand name of VIVA spreaded over
North India.
At present We have 100 Pharmacy Stores which are likely to increase upto 250 by the end of 2011.
OTC / FMCG business venture is also launched.
A Group worth INR 1200 crores ( USD 250 millions)
3
8/12/2019 Surya Corp
4/13
SPL ranks 398 in the prestigious FORTUNE India 500 list
& Ranked no: 20 in Indian Pharmaceutical Sector
8/12/2019 Surya Corp
5/13
SPL has ranked 398 in the prestigious FORTUNE India 500 list! The
Fortune India 500 list features India`s LARGEST CORPORATIONS!
Not only that, it outranked Pharmaceutical giants like Aventis Pharma, Alembic, Arch Pharmalabs and AnkurDrugs to climb to number 20 in the top Drugs & Pharmaceuticals companies of India!
Companies in the Fortune 500 list are ranked on the parameters of both Revenue & Income, they are
ranked by their latest annual audited total income for the financial year ending on or before June 30,
2010. The Total Income includes Core Operating Income ( Net sales) plus other ExtraordinaryIncome. Audited results declared before October 31st, 2010 have been used for the calculations. The
numbers have been sourced from two corporate databases- the Centre for Monitoring of Indian
Economies Prowess and Capitaline Plus by Capital Market Publishers India.
8/12/2019 Surya Corp
6/13
Surya Group
8/12/2019 Surya Corp
7/13
Diabetic
Footwear
Personal
care
Diagnostic
and Medical
Devices
Foot Care
Medical
shoes for
diabetic
patients
Classical
Diabetic
Neuropat
hy
Skin
Care
Baby
Care
Lip Care
OTC
Health
Care
BP
Monitors
Glucose
Monitor
Brand The Power Brand Strategy
Skin
Care
Feeding
Bottles
Baby care
Sports
Nutrition
Supplement
Bodybuildin
g Nutrition
Weight
Managemen
t Nutrition
8/12/2019 Surya Corp
8/13
EXP ND
INNOV TECQUIRE
A Three Pronged Strategy for Sustaining
Growth
Strategic Intent To double revenues and profits in the next coming years.
8/12/2019 Surya Corp
9/13
SPLOn The Growth Path
Sales in crores 2004 to 2010
0
200
400
600
800
1000
1200
1400
Sales Growth
2004
20052006
2007
2008
2009
2010
8/12/2019 Surya Corp
10/13
Surya Pharmaceutical LtdGrowth Trends
8/12/2019 Surya Corp
11/13
Net Profit 2004 to 2010
8/12/2019 Surya Corp
12/13
Surya Pharmaceutical Ltd Annual Report
2009-2010 Cash & Net Profit
8/12/2019 Surya Corp
13/13
Recommended